126 related articles for article (PubMed ID: 9065257)
1. [RO 48-6791--a short acting benzodiazepine. Pharmacokinetics and pharmacodynamics in young and old subjects in comparison to midazolam].
Hering W; Ihmsen H; Albrecht S; Schwilden H; Schüttler J
Anaesthesist; 1996 Dec; 45(12):1211-4. PubMed ID: 9065257
[TBL] [Abstract][Full Text] [Related]
2. Integrated pharmacokinetics and pharmacodynamics of Ro 48-6791, a new benzodiazepine, in comparison with midazolam during first administration to healthy male subjects.
Dingemanse J; van Gerven JM; Schoemaker RC; Roncari G; Oberyé JJ; van Oostenbruggen MF; Massarella J; Segala P; Zell M; Cohen AF
Br J Clin Pharmacol; 1997 Nov; 44(5):477-86. PubMed ID: 9384465
[TBL] [Abstract][Full Text] [Related]
3. Integrated pharmacokinetics and pharmacodynamics of Ro 48-8684, a new benzodiazepine, in comparison with midazolam during first administration to healthy male subjects.
van Gerven JM; Roncari G; Schoemaker RC; Massarella J; Keesmaat P; Kooyman H; Heizmann P; Zell M; Cohen AF; Dingemanse J
Br J Clin Pharmacol; 1997 Nov; 44(5):487-93. PubMed ID: 9384466
[TBL] [Abstract][Full Text] [Related]
4. Modelling acute tolerance to the EEG effect of two benzodiazepines.
Ihmsen H; Albrecht S; Hering W; Schüttler J; Schwilden H
Br J Clin Pharmacol; 2004 Feb; 57(2):153-61. PubMed ID: 14748814
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic-pharmacodynamic modelling of the EEG effects of Ro 48-6791, a new short-acting benzodiazepine, in young and elderly subjects.
Dingemanse J; Häussler J; Hering W; Ihmsen H; Albrecht S; Zell M; Schwilden H; Schüttler J
Br J Anaesth; 1997 Nov; 79(5):567-74. PubMed ID: 9422892
[TBL] [Abstract][Full Text] [Related]
6. The effect of age on the pharmacokinetics and pharmacodynamics of midazolam.
Albrecht S; Ihmsen H; Hering W; Geisslinger G; Dingemanse J; Schwilden H; Schüttler J
Clin Pharmacol Ther; 1999 Jun; 65(6):630-9. PubMed ID: 10391668
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the sedation and recovery profiles of Ro 48-6791, a new benzodiazepine, and midazolam in combination with meperidine for outpatient endoscopic procedures.
Tang J; Wang B; White PF; Gold M; Gold J
Anesth Analg; 1999 Oct; 89(4):893-8. PubMed ID: 10512261
[TBL] [Abstract][Full Text] [Related]
8. A placebo- and midazolam-controlled phase I single ascending-dose study evaluating the safety, pharmacokinetics, and pharmacodynamics of remimazolam (CNS 7056): Part II. Population pharmacokinetic and pharmacodynamic modeling and simulation.
Wiltshire HR; Kilpatrick GJ; Tilbrook GS; Borkett KM
Anesth Analg; 2012 Aug; 115(2):284-96. PubMed ID: 22253270
[TBL] [Abstract][Full Text] [Related]
9. Pharmacodynamic interaction between midazolam and a specific benzodiazepine antagonist in humans.
Klotz U; Ziegler G; Ludwig L; Reimann IW
J Clin Pharmacol; 1985 Sep; 25(6):400-6. PubMed ID: 2865275
[TBL] [Abstract][Full Text] [Related]
10. A pilot pharmacokinetic-pharmacodynamic study of benzodiazepine antagonism by flumazenil and aminophylline.
Bonfiglio MF; Fisher-Katz LE; Saltis LM; Traeger SM; Martin BR; Nackes NA; Perkins TA
Pharmacotherapy; 1996; 16(6):1166-72. PubMed ID: 8947991
[TBL] [Abstract][Full Text] [Related]
11. A placebo- and midazolam-controlled phase I single ascending-dose study evaluating the safety, pharmacokinetics, and pharmacodynamics of remimazolam (CNS 7056): Part I. Safety, efficacy, and basic pharmacokinetics.
Antonik LJ; Goldwater DR; Kilpatrick GJ; Tilbrook GS; Borkett KM
Anesth Analg; 2012 Aug; 115(2):274-83. PubMed ID: 22190555
[TBL] [Abstract][Full Text] [Related]
12. Differences in intrinsic efficacy of benzodiazepines are reflected in their concentration-EEG effect relationship.
Mandema JW; Kuck MT; Danhof M
Br J Pharmacol; 1992 Jan; 105(1):164-70. PubMed ID: 1350744
[TBL] [Abstract][Full Text] [Related]
13. [Concentration-effect relationship, hemodynamics and respiration after infusion of the steroid anesthetic eltanolone in healthy subjects].
Hering W; Ihmsen H; Uhrlau C; Schüttler J
Anaesthesist; 1996 Dec; 45(12):1142-50. PubMed ID: 9065247
[TBL] [Abstract][Full Text] [Related]
14. Auditory and electroencephalographic effects of midazolam and alpha-hydroxy-midazolam in healthy subjects.
Hotz MA; Ritz R; Linder L; Scollo-Lavizzari G; Haefeli WE
Br J Clin Pharmacol; 2000 Jan; 49(1):72-9. PubMed ID: 10606840
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetic-EEG effect relationship of midazolam in aging BN/BiRij rats.
Hovinga S; Stijnen AM; Langemeijer MW; Mandema JW; van Bezooijen CF; Danhof M
Br J Pharmacol; 1992 Sep; 107(1):171-7. PubMed ID: 1422570
[TBL] [Abstract][Full Text] [Related]
16. In vivo modeling of the pharmacodynamic interaction between benzodiazepines which differ in intrinsic efficacy.
Mandema JW; Kuck MT; Danhof M
J Pharmacol Exp Ther; 1992 Apr; 261(1):56-61. PubMed ID: 1560385
[TBL] [Abstract][Full Text] [Related]
17. Intranasal midazolam: pharmacokinetics and pharmacodynamics assessed by quantitative EEG in healthy volunteers.
Hardmeier M; Zimmermann R; Rüegg S; Pflüger M; Deuster S; Suter K; Donzelli M; Drewe J; Krähenbühl S; Fuhr P; Haschke M
Clin Pharmacol Ther; 2012 May; 91(5):856-62. PubMed ID: 22453191
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics, pharmacodynamics, and tolerability of USL261, midazolam nasal spray: Randomized study in healthy geriatric and non-geriatric adults.
Berg AK; Myrvik MJ; Van Ess PJ
Epilepsy Behav; 2017 Jun; 71(Pt A):51-59. PubMed ID: 28544992
[TBL] [Abstract][Full Text] [Related]
19. Benzodiazepine site pharmacokinetic/pharmacodynamic quantification in man: direct measurement of drug occupancy and effects on the human brain in vivo.
Malizia AL; Gunn RN; Wilson SJ; Waters SH; Bloomfield PM; Cunningham VJ; Nutt DJ
Neuropharmacology; 1996; 35(9-10):1483-91. PubMed ID: 9014164
[TBL] [Abstract][Full Text] [Related]
20. Electrophysiological aspects of benzodiazepine antagonists, Ro 15-1788 and Ro 15-3505.
Gath I; Weidenfeld J; Collins GI; Hadad H
Br J Clin Pharmacol; 1984 Oct; 18(4):541-7. PubMed ID: 6435655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
